BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastroenterol. Oct 21, 2025; 31(39): 110751
Published online Oct 21, 2025. doi: 10.3748/wjg.v31.i39.110751
Table 2 Comparison of pathological characteristics between two groups, mean ± SD/n (%)
Parameters
Non-transfusion group (n = 108)
Transfusion group (n = 92)
t/χ2 value
P value
Tumor size (cm)2.81 ± 1.022.89 ± 1.100.5140.608
Node count27.33 ± 11.4327.24 ± 10.240.0600.952
Tumor location6.8430.077
Upper third10 (9.26)3 (3.26)
Middle third39 (36.11)24 (26.09)
Lower third57 (52.78)64 (69.57)
Entire2 (1.85)1 (1.09)
Histology0.4060.816
Differentiated48 (44.44)41 (44.57)
Undifferentiated56 (51.85)49 (53.26)
Others4 (3.70)2 (2.17)
T stage5.7260.017
≤ T265 (60.19)70 (76.09)
> T243 (39.81)22 (23.91)
N stage0.4360.509
N056 (51.85)52 (56.52)
≥ N152 (48.15)40 (43.48)
Gastrectomy0.0610.805
Distal subtotal71 (65.74)62 (67.39)
Total7 (34.26)30 (32.61)
Access2.7870.095
Open53 (49.07)56 (60.87)
Laparoscopic55 (50.93)36 (39.13)
Operation time (minute)243.55 ± 74.35246.68 ± 77.330.2920.771
Intraoperative blood loss (mL)299.72 ± 36.72322.03 ± 62.653.0040.003


Write to the Help Desk